Fluconazole monotherapy for cryptococcosis in non-AIDS patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 10, 1996, Pages 787-792

  Yamaguchi, H ^a   Ikemoto, H ^b   Watanabe, K ^b   Ito, A ^c   Hara, K ^d   Kohno, S ^d  

^a TEIKYO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIGEN; FLUCONAZOLE;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRYPTOCOCCOSIS; FEMALE; FUNGAL MENINGITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL;

ADULT; AGED; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; FLUCONAZOLE; HIV SERONEGATIVITY; HUMANS; LUNG DISEASES, FUNGAL; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED;

EID: 0029989333     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01701520     Document Type: Article

References (10)

1. Armstrong DP: Treatment of opportunistic fungal infections. Clinical Infectious Diseases 1993, 16: 1-9.
2. Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, Leonard J, Fields BT, Bradshaw M, Haywood H, McGee ZA, Cate TR, Cobbs CG, Warner JF, Alling DW: A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New England Journal of Medicine 1979, 301: 126-131.
3. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Draven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, Shadomy S, Stamm AM, Diasio RB, Kaufman L, Soong S, Blackwelder WC: Treatment of cryptococcal meningitis with combination of amphotericin B and flucytosine for four as compared with six weeks. New England Journal of Medicine 1987, 317: 3334-3341.
4. Stamm AM, Diasio RB, Dismukes WE, Shadomy S, Cloud GA, Bowles CA, Karam GH: Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. American Journal of Medicine 1987, 83: 236-242.
5. Dismukes WE: Cryptococcal meningitis in patients with AIDS. Journal of Infectious Diseases 1988, 157: 624-628.
6. Stern JJ, Hartman BJ, Sharkley P, Rowland V, Squires KE, Murray HW, Graybill JR: Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. American Journal of Medicine 1988, 85: 477-480.
7. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco H, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafener R, Dismukes WE: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. New England Journal of Medicine 1992, 326: 83-89.
8. Yagamuchi H: Chemotherapy of cryptococcal meningitis and other forms of cryptococcosis: recent developments and trends. Journal of the Asian Medical Association Southeast Asia 1994, 10, Supplement: 217-219.
9. Debruyne D, Ryckelynck JP: Clinical pharmacokinetics of fluconazole. Clinical Pharmacokinetics 1993, 24: 10-27.
10. Lim SG, Sawyer AM, Hudson M, Sercombe J, Pounder RE: The absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Alimentary Pharmacology and Therapy 1993, 7: 317-321.